Tessera Defense & Homeland Security Inc. (HLSQ)
Sector: Services-Prepackaged Software
Industry: Biotechnology
Tessera Defense and Homeland Security Inc
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 0.0224 | 0.0245 | 0.0200 | 0.0244 | 297,363 |
| Nov 16, 2026 | 0.0224 | 0.0245 | 0.0224 | 0.0224 | 81,304 |
| Nov 13, 2026 | 0.0270 | 0.0300 | 0.0216 | 0.0245 | 814,847 |
| Nov 12, 2026 | 0.0421 | 0.0478 | 0.0235 | 0.0310 | 1,647,492 |
| Nov 11, 2026 | 0.0301 | 0.0590 | 0.0300 | 0.0479 | 1,417,548 |
| Nov 10, 2026 | 0.1100 | 0.1176 | 0.0674 | 0.0717 | 1,730,773 |
| Nov 9, 2026 | 0.1398 | 0.1402 | 0.1145 | 0.1146 | 3,945,027 |
| Nov 6, 2026 | 0.1420 | 0.1470 | 0.1300 | 0.1326 | 320,260 |
| Nov 5, 2026 | 0.1400 | 0.1400 | 0.1158 | 0.1241 | 707,682 |
| Nov 4, 2026 | 0.1500 | 0.1594 | 0.1419 | 0.1440 | 509,500 |
| Nov 3, 2026 | 0.1555 | 0.1750 | 0.1461 | 0.1463 | 293,784 |
| Nov 2, 2026 | 0.1700 | 0.1700 | 0.1500 | 0.1561 | 750,587 |
| Oct 30, 2026 | 0.1746 | 0.1799 | 0.1630 | 0.1718 | 402,520 |
| Oct 29, 2026 | 0.1806 | 0.1904 | 0.1707 | 0.1800 | 855,930 |
| Oct 28, 2026 | 0.2190 | 0.2190 | 0.1617 | 0.1770 | 1,245,815 |
| Oct 27, 2026 | 0.2073 | 0.2160 | 0.1850 | 0.2073 | 830,051 |
| Oct 26, 2026 | 0.2681 | 0.2784 | 0.2080 | 0.2131 | 889,515 |
| Oct 23, 2026 | 0.2715 | 0.2918 | 0.2400 | 0.2605 | 200,992 |
| Oct 22, 2026 | 0.2421 | 0.2853 | 0.2380 | 0.2715 | 865,813 |
| Oct 21, 2026 | 0.2291 | 0.2600 | 0.2165 | 0.2390 | 573,152 |
| Name | Shares | % | Source |
|---|---|---|---|
Ram Naim · joint filing· may incl. warrants· filed Oct 2026 | 477.6K | 1.8% | 13D |
T3 Defense Inc. · joint filing· may incl. warrants· filed Sep 2026 | 156.8K | 0.6% | 13D |
Nantahala Capital Management, LLC · net of 13F· joint filing· may incl. warrants· filed Nov 2026 | 73.1K | 0.3% | 13G |
Nantahala Capital Management, LLC | 63.5K | 0.2% | 13F |
Mandragola Ltd. · joint filing· may incl. warrants· filed Oct 2026 | 55.4K | 0.2% | 13G |
HRT FINANCIAL LP | 53.4K | 0.2% | 13F |
Deerfield Management Company, L.P. · joint filing· may incl. warrants· filed Jun 2026 | 53.3K | 0.2% | 13D |
TWO SIGMA SECURITIES, LLC | 17.6K | 0.1% | 13F |
UBS Group AG | 14.1K | 0.1% | 13F |
CITADEL ADVISORS LLC | 12.6K | 0.0% | 13F |
Insiders
- Cystic Fibrosis Foundation10% Owner
- Solomon Jonathan EitanChief Executive Officer, Director
- Bassan MeravChief Development Officer
- Wolfson MarinaChief Financial Officer
- Oron AssafChief Business Officer
Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis.
Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively.
The company was founded in March 2015 and is headquartered in Dover, DE.
based on 26.00M shares outstanding
30d Avg
1.36M
60d Avg
1.32M
90d Avg
1.31M
Signal8's dilution snapshot of HLSQ as of Jun 30, 2026 records an effective S-3 shelf registration (effective Feb 13, 2026), an at-the-market sales agreement dated Dec 7, 2023, 12 outstanding warrant series and an ATM sale closed Jun 30, 2026, from SEC filings. Tessera Defense & Homeland Security Inc. (OTC: HLSQ) traded at $0.0244 on Nov 17, 2026, up 8.93% from the previous close of $0.0224. 52-week range: $0.0200 to $0.8425. The company is in the Healthcare sector (Biotechnology).